Cognivue is proud to support Davos Alzheimer’s Collaborative and their global efforts to fight Alzheimer’s Disease
Geneva, 21 September 2021 – The Davos Alzheimer’s Collaborative (DAC) is a global multi-stakeholder partnership that is mobilizing the world against Alzheimer’s disease. DAC announced today it has successfully completed financing of its foundational phase and has launched several key initiatives to advance Alzheimer’s research, prevention and care to advance the fight against the disease.
A recent WHO report shows that Alzheimer’s and dementia impacted more than 55 million families worldwide and cost the global economy approximately US$1.3 trillion in 2019. This annual cost is expected to rise to $2.8 trillion by 2030, based on predicted increases in cases and the cost of care. By averaging these numbers to assume an approximate annual cost of $2 trillion through 2030, we estimate the disease will cost the global economy a cumulative $20 trillion over the next decade.
Due to rapid gains in global life expectancy, more than 70% of Alzheimer’s cases will be in low- and middle-income countries (LMICs) by 2050, inhibiting their prospects for growth and exacerbating health and economic disparities between LMICs and higher-income countries. By contrast, nearly 80% of genomic analysis has come from people of European descent, even though more than 80% of the global population is not of European descent.
New advances in treatment have accelerated investment and innovation in the space, building momentum for change and increasing the urgency for healthcare systems to be prepared for major changes in how they care for patients with the disease in the coming years.
